Compare with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ANG LIFESCIENCES INDIA vs WOCKHARDT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ANG LIFESCIENCES INDIA WOCKHARDT ANG LIFESCIENCES INDIA/
WOCKHARDT
 
P/E (TTM) x - -108.9 - View Chart
P/BV x 15.7 1.4 1,102.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ANG LIFESCIENCES INDIA   WOCKHARDT
EQUITY SHARE DATA
    ANG LIFESCIENCES INDIA
Mar-20
WOCKHARDT
Mar-21
ANG LIFESCIENCES INDIA/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs66570 11.5%   
Low Rs28174 16.2%   
Sales per share (Unadj.) Rs244.8249.3 98.2%  
Earnings per share (Unadj.) Rs11.862.2 18.9%  
Cash flow per share (Unadj.) Rs14.184.4 16.8%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs66.7302.3 22.1%  
Shares outstanding (eoy) m5.18110.78 4.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.21.5 12.9%   
Avg P/E ratio x4.06.0 66.8%  
P/CF ratio (eoy) x3.34.4 75.4%  
Price / Book Value ratio x0.71.2 57.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m24341,188 0.6%   
No. of employees `000NANA-   
Total wages/salary Rs m717,630 0.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,26827,620 4.6%  
Other income Rs m41,534 0.3%   
Total revenues Rs m1,27329,155 4.4%   
Gross profit Rs m12712,575 1.0%  
Depreciation Rs m122,460 0.5%   
Interest Rs m352,491 1.4%   
Profit before tax Rs m849,159 0.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m232,273 1.0%   
Profit after tax Rs m616,886 0.9%  
Gross profit margin %10.045.5 22.0%  
Effective tax rate %27.524.8 110.8%   
Net profit margin %4.824.9 19.3%  
BALANCE SHEET DATA
Current assets Rs m72724,244 3.0%   
Current liabilities Rs m50931,182 1.6%   
Net working cap to sales %17.2-25.1 -68.5%  
Current ratio x1.40.8 183.7%  
Inventory Days Days130 1.8%  
Debtors Days Days13312 1,093.2%  
Net fixed assets Rs m21449,508 0.4%   
Share capital Rs m52554 9.4%   
"Free" reserves Rs m29432,939 0.9%   
Net worth Rs m34633,492 1.0%   
Long term debt Rs m535,029 1.0%   
Total assets Rs m94173,752 1.3%  
Interest coverage x3.44.7 73.3%   
Debt to equity ratio x0.20.2 101.2%  
Sales to assets ratio x1.30.4 360.0%   
Return on assets %10.212.7 79.9%  
Return on equity %17.620.6 85.8%  
Return on capital %29.830.2 98.6%  
Exports to sales %00-   
Imports to sales %01.8 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA498 0.0%   
Fx inflow Rs m151,009 1.5%   
Fx outflow Rs m1498 0.1%   
Net fx Rs m14511 2.8%   
CASH FLOW
From Operations Rs m48-2,873 -1.7%  
From Investments Rs m-1714,701 -0.1%  
From Financial Activity Rs m-39-11,708 0.3%  
Net Cashflow Rs m-8129 -6.0%  

Share Holding

Indian Promoters % 71.1 68.0 104.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 2.9 -  
FIIs % 0.0 2.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 28.9 32.0 90.5%  
Shareholders   323 161,625 0.2%  
Pledged promoter(s) holding % 21.1 42.0 50.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ANG LIFESCIENCES INDIA With:   WINDLAS BIOTECH  MARKSANS PHARMA.  ORCHID PHARMA  AMRUTANJAN HEALTHCARE  SUVEN LIFE SCIENCES  



Today's Market

Sensex Zooms 777 Points, Nifty Ends Above 17,400; Power & IT Stocks Rally(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

WOCKHARDT 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of WOCKHARDT for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of WOCKHARDT. Also includes updates on the valuation of WOCKHARDT.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ANG LIFESCIENCES INDIA SHARE PRICE


Dec 2, 2021 (Close)

TRACK ANG LIFESCIENCES INDIA

  • Track your investment in ANG LIFESCIENCES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ANG LIFESCIENCES INDIA

ANG LIFESCIENCES INDIA 8-QTR ANALYSIS

COMPARE ANG LIFESCIENCES INDIA WITH

MARKET STATS